Influences of Phenylephrine, Dopamine and Ephedrine on Stroke Volume Variation and Pulse Pressure Variation

NCT ID: NCT02201121

Last Updated: 2014-07-25

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

94 participants

Study Classification

INTERVENTIONAL

Study Start Date

2014-03-31

Study Completion Date

2014-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Although induced hypertension decreased SVV and PPV,the influences of stroke volume variation and pulse pressure variation caused by phenylephrine,dopamine and ephedrine were unknown.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Pulse pressure variation (PPV) and stroke volume variation (SVV) during mechanical ventilation have been shown to be effective parameters to predict preload responsiveness. Although induced hypertension decreases PPV and SVV, the influences of phenylephrine, dopamine and ephedrine on PPV and SVV are unknown.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Circulation Drug Dose Calculated SAP

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

phenylephrine group, dopamine group, ephedrine group

phenylephrine group: use the phenylephrine to increase the SAP from low to high level.

dopamine group: use the dopamine to increase the SAP from low to high level. ephedrine group:use the ephedrine to increase the SAP from low to high level.

Group Type EXPERIMENTAL

Influences of phenylephrine, dopamine and ephedrine on stroke volume variation and pulse pressure variation

Intervention Type OTHER

This research mainly study the effect of clinical commonly used vasoconstrictor drugs on blood pressure of pressure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Influences of phenylephrine, dopamine and ephedrine on stroke volume variation and pulse pressure variation

This research mainly study the effect of clinical commonly used vasoconstrictor drugs on blood pressure of pressure

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Their American Society of Anesthesiologists (ASA) physical status was 1 or 2
* Body mass index (BMI) ranged from 18 to 26
* None of the patients had known diabetes mellitus, hypertension, cardiovascular, pulmonary, endocrinological, neurological diseases, or diseases that influenced intravascular fluid volume or balance
* All patients had a preoperative fast for at least 8 h and routine atropine intramuscular injection

Exclusion Criteria

* Persistent arrhythmias
* Intraoperative application of vasoactive drugs except phenylephrine, dopamine and ephedrine
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Chinese PLA General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Ran Kong

Department of Anesthesiology, People's Liberation Army General Hospital, Beijing, China

Responsibility Role PRINCIPAL_INVESTIGATOR

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

plaghran001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Leptin Infusion and Endothelial Vasomotor Response
NCT04374500 COMPLETED EARLY_PHASE1
Sympathetic Mechanisms in Obesity-Crossover Design
NCT05312892 RECRUITING PHASE1/PHASE2